Holen Sie sich die Stockscreener-App
2.28
10.94%
-0.28
Handel nachbörslich:
2.24
-0.04
-1.75%
Schlusskurs vom Vortag:
$2.56
Offen:
$2.55
24-Stunden-Volumen:
4.28M
Relative Volume:
1.15
Marktkapitalisierung:
$518.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-1.7143
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
-11.28%
1M Leistung:
-26.69%
6M Leistung:
+193.44%
1J Leistung:
+131.78%
1-Tages-Spanne:
$2.21
$2.575
1-Wochen-Bereich:
$2.21
$2.61
52-Wochen-Spanne:
$0.6617
$3.60
Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
Gossamer Bio Inc
Sektor
Branche
Telefon
(858) 684-1300
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.28 | 585.93M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-10 | Hochstufung | UBS | Neutral → Buy |
| 2025-07-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-19 | Eingeleitet | Wedbush | Outperform |
| 2022-04-18 | Eingeleitet | Raymond James | Outperform |
| 2022-04-06 | Eingeleitet | UBS | Buy |
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-30 | Eingeleitet | Berenberg | Buy |
| 2019-03-05 | Eingeleitet | Barclays | Overweight |
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform |
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
Applying chart zones and confluence areas to Gossamer Bio Inc.2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Intraday pattern recognizer results for Gossamer Bio Inc.July 2025 Review & Fast Gain Stock Tips - newser.com
Using data tools to time your Gossamer Bio Inc. exit2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
Will Gossamer Bio Inc. (4GB) stock outperform benchmarksWeekly Market Report & Reliable Price Breakout Alerts - newser.com
Using economic indicators to assess Gossamer Bio Inc. potentialEarnings Growth Report & Pattern Based Trade Signal System - newser.com
Real time alert setup for Gossamer Bio Inc. performanceTrade Signal Summary & Safe Capital Allocation Plans - newser.com
Historical volatility pattern of Gossamer Bio Inc. visualizedMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Evaluating Gossamer Bio Inc. with trendline analysisNew Guidance & Smart Investment Allocation Insights - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Gossamer Bio (NASDAQ:GOSS) - MarketBeat
Brokerages Set Gossamer Bio, Inc. (NASDAQ:GOSS) Price Target at $8.50 - Defense World
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 5.6%Time to Sell? - MarketBeat
What dividend safety score for Gossamer Bio Inc. stockGlobal Markets & Weekly Return Optimization Alerts - newser.com
How institutional ownership impacts Gossamer Bio Inc. stockWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Smart tools for monitoring Gossamer Bio Inc.’s price actionBear Alert & AI Enhanced Trade Execution Alerts - newser.com
Gossamer Bio Inc. stock trend outlook and recovery pathDividend Hike & Verified Trade Idea Suggestions - newser.com
Advanced analytics toolkit walkthrough for Gossamer Bio Inc.Market Performance Report & AI Powered Market Entry Strategies - newser.com
Is it time to cut losses on Gossamer Bio Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Published on: 2025-10-05 03:04:10 - newser.com
Why institutional investors increase stakes in Gossamer Bio Inc. (4GB) stockWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Can Gossamer Bio Inc. (4GB) stock withstand sector downturnsWall Street Watch & Stock Portfolio Risk Control - newser.com
What’s next for Gossamer Bio Inc. stock priceDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Is Gossamer Bio Inc. (4GB) stock supported by strong fundamentalsWeekly Profit Recap & Verified Momentum Stock Watchlist - newser.com
What candlestick patterns are forming on Gossamer Bio Inc.July 2025 Trends & High Conviction Trade Alerts - newser.com
Platinum Investment Management Ltd. Cuts Position in Gossamer Bio, Inc. $GOSS - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Trading Down 5.1%Time to Sell? - MarketBeat
Published on: 2025-09-29 14:34:15 - newser.com
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):